Company intelligence / Profile preview
Aurora Biopharma
Cambridge, Massachusetts, United Statesaurora-biopharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Aurora Biopharma develops autologous CAR-T therapies targeting HER2 for resistant solid tumors. Completed two clinical trials with promising safety and efficacy signals in glioblastoma and sarcoma. Ongoing/recruiting studies include osteosarcoma and recurrent glioblastoma. Early results show strong tumor-killing activity, survival benefits, and objective response rates above historical controls.
- Therapeutic areas
- Oncology
- Modalities
- Autologous CAR-T cell therapyCancer immunotherapy (adoptive cell transfer)Chimeric Antigen Receptor T-cell therapy (CAR T)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaboration with a major pharmaceutical company on combination trial of MedVax’s MX‑225 vaccine with PD‑1 antibody in lung cancer; collaboration at Moffitt Cancer Center for breast cancer vaccine trial.
Beyond the preview
Go deeper on Aurora Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aurora Biopharma.